Tandem Diabetes Care, Inc.
Viés de alta

Smart money created and bought the dip

163
Recent analyst downgrade was no less than pure manipulation to create new long term holders, most likely institutional holders as we are approaching the Sep 25th conference. Most analysts are still bullish, and there are several catalysts ahead through 2020 like t:sport, Control-IQ, sales on Basal-IQ, international expansion, and possible UHC coverage. Tandem also seems to have a great management team.

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.